RecruitingNot ApplicableNCT05645003

Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients

Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury

Sponsor

Afyonkarahisar Health Sciences University

Enrollment

60 participants

Start Date

Nov 15, 2022

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injuries Neuropathic Pain Neurological Diseases or Conditions

Summary

The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury. In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain. In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.

Eligibility

Min Age: 20 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called High-frequency real-time rTMS protocol and a medical device called Sham rTMS Protocol for people with neurological diseases or conditions, neuropathic pain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHigh-frequency real-time rTMS protocol

It was planned to apply a total of 1200 beats to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.

DEVICESham rTMS Protocol

It was planned to apply a to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.